BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36346345)

  • 1. Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.
    Shao H; Shi D; Dai Y
    Br J Clin Pharmacol; 2023 Apr; 89(4):1386-1392. PubMed ID: 36346345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes and QT prolongation Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.
    Teng C; Walter EA; Gaspar DKS; Obodozie-Ofoegbu OO; Frei CR
    Int J Med Sci; 2019; 16(7):1018-1022. PubMed ID: 31341415
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Torsade de Pointes and QT Prolongation With Antifungal Triazoles: Analysis Using a Pharmacovigilance Database.
    Ohyama K; Akiyama S; Iida M; Hori Y
    In Vivo; 2023; 37(6):2719-2725. PubMed ID: 37905641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.
    Diaby V; Almutairi RD; Chen Z; Moussa RK; Berthe A
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):159-168. PubMed ID: 33186061
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system.
    Ali Z; Ismail M; Khan F; Sajid H
    Expert Opin Drug Saf; 2021 Jan; 20(1):101-107. PubMed ID: 33141610
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Rochoy M; Auffret M; Béné J; Gautier S;
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System(FAERS).
    Yu Z; Liao X
    J Pharm Pharm Sci; 2022; 25():237-243. PubMed ID: 35790147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid and the risk of lactic acidosis: Data mining and analysis of the FDA Adverse Event Reporting System.
    Dai Y; Wang Y; Zeng Y; Zhang C; Zhou Z; Shi D
    J Clin Pharm Ther; 2020 Dec; 45(6):1422-1426. PubMed ID: 32776380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.
    Saint-Gerons DM; Tabarés-Seisdedos R
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1513-1521. PubMed ID: 33938974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
    Kao DP; Haigney MC; Mehler PS; Krantz MJ
    Addiction; 2015 Sep; 110(9):1468-75. PubMed ID: 26075588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system.
    Yan Y; Wu B; Wang L
    Expert Opin Drug Saf; 2024 Mar; ():1-8. PubMed ID: 38482864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data.
    Kao D; Bucher Bartelson B; Khatri V; Dart R; Mehler PS; Katz D; Krantz MJ
    Ann Intern Med; 2013 May; 158(10):735-40. PubMed ID: 23689766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
    Salem JE; Dureau P; Bachelot A; Germain M; Voiriot P; Lebourgeois B; Trégouët DA; Hulot JS; Funck-Brentano C
    JAMA Cardiol; 2018 Sep; 3(9):877-882. PubMed ID: 30073300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation.
    Singh AP; Tousif S; Umbarkar P; Lal H
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32549293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system.
    Wu Z; Zhou P; He N; Zhai S
    Front Cardiovasc Med; 2022; 9():966331. PubMed ID: 36352852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
    Sarganas G; Garbe E; Klimpel A; Hering RC; Bronder E; Haverkamp W
    Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors.
    Grouthier V; Lebrun-Vignes B; Glazer AM; Touraine P; Funck-Brentano C; Pariente A; Courtillot C; Bachelot A; Roden DM; Moslehi JJ; Salem JE
    Heart; 2018 Nov; 104(22):1859-1863. PubMed ID: 29720397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics and risk of QT prolongation: a pharmacovigilance study.
    Bordet C; Garcia P; Salvo F; Touafchia A; Galinier M; Sommet A; Montastruc F
    Psychopharmacology (Berl); 2023 Jan; 240(1):199-202. PubMed ID: 36515735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.